| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 137.38B | 142.91B | 138.18B | 137.91B | 139.49B | 127.64B |
| Gross Profit | 39.17B | 40.97B | 37.28B | 36.51B | 34.03B | 33.74B |
| EBITDA | 15.43B | 16.73B | 15.35B | 15.52B | 13.75B | 14.07B |
| Net Income | 12.43B | 14.18B | 12.94B | 11.48B | 10.02B | 9.07B |
Balance Sheet | ||||||
| Total Assets | 224.74B | 230.08B | 198.31B | 202.07B | 180.59B | 163.56B |
| Cash, Cash Equivalents and Short-Term Investments | 22.41B | 19.57B | 16.61B | 21.34B | 14.60B | 14.17B |
| Total Debt | 32.80B | 13.15B | 6.55B | 2.97B | 12.79B | 6.75B |
| Total Liabilities | 64.10B | 62.33B | 47.45B | 54.10B | 51.62B | 44.76B |
| Stockholders Equity | 159.66B | 166.74B | 149.98B | 147.10B | 128.19B | 118.12B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -4.07B | -4.79B | 16.72B | -5.57B | 8.01B |
| Operating Cash Flow | 0.00 | 10.04B | 2.02B | 22.04B | -213.00M | 12.84B |
| Investing Cash Flow | 0.00 | -7.71B | -5.26B | -3.24B | -3.52B | -5.82B |
| Financing Cash Flow | 0.00 | -1.54B | -3.03B | -13.49B | 3.31B | -5.39B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥617.79B | 17.43 | 13.63% | 1.95% | -1.79% | 1.03% | |
73 Outperform | ¥177.28B | 10.76 | ― | 2.66% | -4.58% | 51.25% | |
69 Neutral | ¥184.13B | 7.84 | 8.27% | 2.68% | 3.42% | 13.11% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥915.68B | 9.71 | 7.53% | 3.13% | 0.89% | -6.71% | |
61 Neutral | ¥4.43B | 10.21 | ― | 2.79% | 4.46% | 21.15% | |
46 Neutral | ¥307.83B | -3.58 | -20.43% | 3.72% | -13.16% | -410.43% |